IDEAYA Biosciences begins phase 1/2 clinical trial to evaluate IDE397 and Trodelvy combination in MTAP-deletion urothelial cancer

Join Pharma | Login

	Editorial


	EPC MD GETS WINGS
	Wednesday, April 9, 2025
	After the initial hiccups, the Department of Pharmaceuticals has recently put the ball rolling for the full-fledged functioning of the Export Promotion Council for Medical Devices (EPC MD).
	Past Editorial...

TODAY'S NEWS


17:00 [IST]	IDEAYA Biosciences begins phase 1/2 clinical trial to evaluate IDE397 and Trodelvy combination in MTAP-deletion urothelial cancer
16:00 [IST]	Shuttle Pharma seeks US patent for PSMA Ligand Conjugates to treat prostate cancer
15:00 [IST]	Oculis Holding completes enrollment in both DIAMOND phase 3 clinical trials of OCS-01 in diabetic macular edema
14:40 [IST]	Ujala Cygnus and Amandeep Group of Hospitals announce strategic partnership to expand healthcare across North India
14:20 [IST]	Woxsen University develops AI-driven necrobotic system to advance in robotic-assisted surgery
14:00 [IST]	Eyenovia provides development update on Optejet user filled device

more news >>

TOP NEWS


08:00 [IST]	PCI asks institutions to take necessary action on PETA's request to ban Forced Swim Test
08:00 [IST]	Higher US tariffs will make Indian pharmaceuticals less competitive in US market: experts
08:00 [IST]	NPPA revises ceiling price of diagnostic agent following DoP's review order
08:00 [IST]	NIB not recognizing Pharm D as a Master Degree qualification for scientist post
08:00 [IST]	Indian pharma moving towards Green Pharma 2.0 where AI, digital twins, sustainable molecule design prevail
08:00 [IST]	PCI adds M.Pharm Pharmacy Practice as qualification for clinical pharmacist

more news >>

YESTERDAY'S NEWS


18:00 [IST]	Theriva Biologics presents data from phase 1b/2a trial of ribaxamase in allogeneic hematopoietic cell transplant recipients
17:00 [IST]	Adaptin Bio completes alternative public offering and closes $7.7 million private placement
16:00 [IST]	Oncodesign Services appoints Aidan Synnott as CEO to enhance drug discovery
14:30 [IST]	IPU 2025 to usher in a new era of digital, inclusive, and accountable healthcare
14:15 [IST]	AMTZ joins hands with FORGE to build India’s strongest medtech innovation ecosystem
16:15 [IST]	Maharashtra FDA cracks down on clandestine, illegal cosmetic operations in Bhiwandi

more news >>

INTERVIEW


All DIs in TN are fully competent to inspect manufacturing units as per Revised Schedule M: MN Sridhar
MN Sridhar, director of the Tamil Nadu Drugs Control Department

Past Interviews...

	What's New?

US tariff exemption to bolster Indian pharma global presence with supply of high quality medicines Insulin Aspart 100 Iu/ml, Pack Of 3 Ml Brivaracetam 100mg Tab Mebeverine 135mg Tab Levofloxacin 500mg 100ml Infusion

Opinion Poll

Will the introduction of Revised Schedule M by Union Health Ministry solve the issue of quality of Indian drugs?

YesNoCan't Say

View Past Poll

Corporate

Special Features

Features

Chronicle Pharmabiz Specials

Forthcoming Events

TENDERS & PROJECTS

	Tenders & Enquiries
	Pharma Projects

CORPORATE

	Company Profile
	Corporate Results
	Corporate X-ray
	Pharmabiz Studies of Top Companies

US FDA UPDATE

EXPORT & IMPORT

	Drug Export Procedures
	Drug Units With WHO GMP Certification
	Pharma Export Data
	Import Reg. Update

PHARMA LAWS & DOCUMENTS

LIST OF LABS & GOVT. BODIES

	Govt Recognised In-House R&D Units
	AICTE Boards & Committees
	List of Indian CROs
	List of CROs (International)
	Govt & approved labs of India
	List of State Drugs Controllers